Lymphocyte News and Research

RSS
Skin phenotype of pediatric eczema opens door for personalized treatment of AD in infants

Skin phenotype of pediatric eczema opens door for personalized treatment of AD in infants

Researchers develop innovative technique for detecting HIV hiding places in infected patients

Researchers develop innovative technique for detecting HIV hiding places in infected patients

Researchers discover how mineral ion leaked from dying tumour tissue stops work of immune cells

Researchers discover how mineral ion leaked from dying tumour tissue stops work of immune cells

Research findings could lead to new ways of preventing or treating organ transplant rejection

Research findings could lead to new ways of preventing or treating organ transplant rejection

Seeds of tropical shrub guarana contain ten times more amount of catechins than green tea

Seeds of tropical shrub guarana contain ten times more amount of catechins than green tea

ECTRIMS previews important sessions ahead of world’s largest annual congress of multiple sclerosis

ECTRIMS previews important sessions ahead of world’s largest annual congress of multiple sclerosis

Immunotherapy drug combination shows prominent therapeutic effect against advanced and metastatic cancers in mice

Immunotherapy drug combination shows prominent therapeutic effect against advanced and metastatic cancers in mice

Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

Scientists discover link between two genes involved in PD and autoimmune diseases

Scientists discover link between two genes involved in PD and autoimmune diseases

Neutral atherosclerosis trial highlights effectiveness of optimal medical therapy

Neutral atherosclerosis trial highlights effectiveness of optimal medical therapy

Real risk of rebound syndrome following fingolimod cessation for MS

Real risk of rebound syndrome following fingolimod cessation for MS

KEYNOTE-001 findings add support to pembrolizumab for advanced melanoma

KEYNOTE-001 findings add support to pembrolizumab for advanced melanoma

Cell-signaling protein holds key to understanding autoantibody formation in lupus patients

Cell-signaling protein holds key to understanding autoantibody formation in lupus patients

Newly developed computer models can simulate stem cell transplant recovery

Newly developed computer models can simulate stem cell transplant recovery

Clinical study finds no added benefit of using four TB drugs to save people with advanced HIV/AIDS

Clinical study finds no added benefit of using four TB drugs to save people with advanced HIV/AIDS

Neural stem cells from T cell-derived iPSCs provide neurological disease model

Neural stem cells from T cell-derived iPSCs provide neurological disease model

New microfluidic biosensor can identify white blood cells quickly for AIDS diagnosis

New microfluidic biosensor can identify white blood cells quickly for AIDS diagnosis

Johns Hopkins Greenberg Bladder Cancer Institute awards grants for 10 bladder cancer research projects

Johns Hopkins Greenberg Bladder Cancer Institute awards grants for 10 bladder cancer research projects

RUVICA (ibrutinib) capsules approved for treatment-naïve CLL patients

RUVICA (ibrutinib) capsules approved for treatment-naïve CLL patients

Research: Adenosine deaminase may help activate immune system against HIV

Research: Adenosine deaminase may help activate immune system against HIV

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.